Amneal accelerates distribution and production of Hydroxychloroquine Sulfate to meet potential needs of COVID-19 patients nationwide

Amneal is ramping up production of hydroxychloroquine sulfate at several of its manufacturing sites and expects to produce approximately 20 million tablets between now and mid-April. Those tablets